Kabra Drugs Limited (BOM:524322)

Kabra Drugs Revenue

In the fiscal year ending March 31, 2026, Kabra Drugs had annual revenue of 927.40M INR. Kabra Drugs had revenue of 354.06M in the quarter ending March 31, 2026.

• Revenue: 927.40M
• Revenue Growth: n/a
• P/S Ratio: 0.65
• Revenue / Employee: 29.92M
• Employees: 31
• Market Cap: 602.89M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	927.40M	-	-
Mar 31, 2025	-	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	-	-	-
Mar 31, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error